Abbrea Capital, LLC Eli Lilly & CO Transaction History

Abbrea Capital, LLC

$755 Million
Q2 2024

A detailed history of Abbrea Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Abbrea Capital, LLC holds 9,579 shares of LLY stock, worth $8.71 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

9,579

Previous 9,654 0.78%

Holding current value

$8.71 Million

Previous $7.51 Million 15.47%

% of portfolio

1.15%

Previous 0.99%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $54,365 - $68,178	-75 Reduced 0.78%	9,579 $8.67 Million
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $135,021 - $180,639	228 Added 2.42%	9,654 $7.51 Million
Q4 2023 Feb 02, 2024	BUY	$525.19 - $619.13 $201,147 - $237,126	383 Added 4.24%	9,426 $5.5 Million
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $94,764 - $130,647	-218 Reduced 2.35%	9,043 $4.86 Million
Q2 2023 Aug 01, 2023	BUY	$350.74 - $468.98 $60,327 - $80,664	172 Added 1.89%	9,261 $4.34 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $40,381 - $47,426	-130 Reduced 1.41%	9,089 $3.12 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $31,511 - $36,717	98 Added 1.07%	9,219 $3.37 Million
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $42,100 - $47,977	-142 Reduced 1.53%	9,121 $2.95 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $8,361 - $9,818	30 Added 0.32%	9,263 $3 Million
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $75,999 - $94,315	338 Added 3.8%	9,233 $2.55 Million
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $55,843 - $68,722	-252 Reduced 2.76%	8,895 $2.06 Million
Q2 2021 Aug 04, 2021	BUY	$180.55 - $233.54 $39,721 - $51,378	220 Added 2.46%	9,147 $2.1 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $27,441 - $35,524	167 Added 1.91%	8,927 $1.67 Million
Q4 2020 Jan 21, 2021	BUY	$130.46 - $172.63 $3,000 - $3,970	23 Added 0.26%	8,760 $1.48 Million
Q3 2020 Oct 20, 2020	SELL	$146.22 - $169.13 $40,502 - $46,849	-277 Reduced 3.07%	8,737 $1.29 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $15,824 - $19,044	116 Added 1.3%	9,014 $1.48 Million
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $128,931 - $159,580	1,083 Added 13.86%	8,898 $1.23 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $4,811 - $5,959	-45 Reduced 0.57%	7,815 $1.03 Million
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $259,499 - $282,268	2,430 Added 44.75%	7,860 $879,000
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $11,743 - $13,707	-106 Reduced 1.91%	5,430 $602,000
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $66,897 - $78,743	601 Added 12.18%	5,536 $718,000
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $23,827 - $26,694	225 Added 4.78%	4,935 $571,000
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $54,521 - $68,141	635 Added 15.58%	4,710 $505,000
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $13,474 - $15,464	-178 Reduced 4.19%	4,075 $348,000
Q1 2018 May 10, 2018	BUY	$74.21 - $87.6 $118,216 - $139,546	1,593 Added 59.89%	4,253 $329,000
Q4 2017 Feb 01, 2018	BUY	$81.94 - $87.89 $16,142 - $17,314	197 Added 8.0%	2,660 $225,000
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $189,823 - $210,685	2,463	2,463 $211,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.

Account

Abbrea Capital, LLC Eli Lilly & CO Transaction History